Volume 21 Issue 2
Feb.  2023
Turn off MathJax
Article Contents
LI Jing, LI Xiao-feng, YAN Ni, LIU Ling-jiao. Evaluation the screening value of obesity-related indices for non-alcoholic fatty liver disease[J]. Chinese Journal of General Practice, 2023, 21(2): 195-198. doi: 10.16766/j.cnki.issn.1674-4152.002843
Citation: LI Jing, LI Xiao-feng, YAN Ni, LIU Ling-jiao. Evaluation the screening value of obesity-related indices for non-alcoholic fatty liver disease[J]. Chinese Journal of General Practice, 2023, 21(2): 195-198. doi: 10.16766/j.cnki.issn.1674-4152.002843

Evaluation the screening value of obesity-related indices for non-alcoholic fatty liver disease

doi: 10.16766/j.cnki.issn.1674-4152.002843
Funds:

 81700735

  • Received Date: 2022-07-13
    Available Online: 2023-04-20
  •   Objective  To explore obesity-related indices suitable for screening non-alcoholic fatty liver disease (NAFLD) in middle-aged and elderly population.  Methods  This cross-sectional study screened 1 281 people aged 40 and above who attended physical examinations at the Health Management Center of Shaanxi Provincial People' s Hospital from January to March 2019. Their medical history was recorded, and they underwent physical examination and laboratory tests. All subjects underwent abdominal ultrasonography. Logistic regression was used to analyse the association between obesity index and the risk of NAFLD. ROC curve was used to evaluate the screening value of obesity indices for the risk of NAFLD.  Results  Among 1 281 subjects, 335 were diagnosed with NAFLD, with a prevalence rate of 26.15%. The blood pressure, triglyceride, total cholesterol, low density lipoprotein cholesterol, transaminase levels, fasting blood glucose, fasting insulin, homeostasis model assessment of insulin resistance, haemoglobin A1c, waist circumference (WC), waist-to-hip ratio (WHR), BMI and lipid accumulation product (LAP) values significantly increased in the NAFLD group, and the high-density lipoprotein cholesterol decreased. Logistic regression analysis showed that WC, WHR, BMI and LAP were significantly correlated with NAFLD after adjusting for confounding factors. Among them, LAP had the strongest correlation with NAFLD. Compared with subjects in the first quartile of LAP, subjects in the fourth quartile had a significantly increased risk of NAFLD (OR=18.055, 95% CI: 7.683-42.427, P < 0.001). The AUC of the four obesity indices were all greater than 0.7, indicating that they had high screening value for NAFLD. LAP had the highest screening value for NAFLD in males and females, with AUC 85.34 (95% CI: 81.78-88.90) in males and AUC 80.22 (95% CI: 76.95-83.48) in females.  Conclusion  LAP is closely associated with the risk of NAFLD and may be an effective tool for screening the disease in middle-aged and elderly people.

     

  • loading
  • [1]
    FERKY B, RIBAS A, BAUMGARTNER C, et al. Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma[J]. Nat Commun, 2018, 9(1): 4349. doi: 10.1038/s41467-018-06648-6
    [2]
    KWASNICKA D, NTOUMANIS N, HUNT K, et al. A gender-sensitised weight-loss and healthy living program for men with overweight and obesity in Australian Football League settings (Aussie-FIT): a pilot randomised controlled trial[J]. PLoS Med, 2020, 17(8): e1003136. DOI: 10.1371/journal.pmed.1003136.
    [3]
    POLYZOS S, KOUNTOURAS J, MANTZOROS C. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics[J]. Metabolism, 2019, 92: 82-97. doi: 10.1016/j.metabol.2018.11.014
    [4]
    LEE S W, SON J Y, KIM J M, et al. Body fat distribution is more predictive of all-cause mortality than overall adiposity[J]. Diabetes Obes Metab, 2018, 20(1): 141-147. doi: 10.1111/dom.13050
    [5]
    KAHN H. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison[J]. Diabetes Care, 2006, 29(1): 151-153. doi: 10.2337/diacare.29.01.06.dc05-1805
    [6]
    孙亮亮, 谢虹, 张艳芳, 等. 蚌埠市某地区成人脂质蓄积指数与糖尿病患病风险关系的研究[J]. 中华全科医学, 2019, 17(7): 1204-1208. doi: 10.16766/j.cnki.issn.1674-4152.000902

    SUN L L, XIE H, ZHANG Y F, et al. Relationship between lipid accumulation product and the risk of diabetes in adults of a region of Bengbu[J]. Chinese Journal of General Practice, 2019, 17(7): 1204-1208. doi: 10.16766/j.cnki.issn.1674-4152.000902
    [7]
    DATTA S, PACHECO E, LUGO R, et al. Evaluation of anthropometric indices and lipid parameters to predict metabolic syndrome among adults in Mexico[J]. Diabetes Metab Syndr Obes, 2021, 14: 691-701. doi: 10.2147/DMSO.S281894
    [8]
    KYROU I, PANAGIOTAKOS D B, KOULI G M, et al. Lipid accumulation product in relation to 10-year cardiovascular disease incidence in Caucasian adults: the ATTICA study[J]. Atherosclerosis, 2018, 279: 10-16. doi: 10.1016/j.atherosclerosis.2018.10.015
    [9]
    MASTROMAURO C, POLIDORI N, GIANNINI C. Metabolic dysfunction-associated fatty liver disease in obese youth with insulin resistance and type 2 diabetes[J]. Curr Opin Pediatr, 2022, 34(4): 414-422. doi: 10.1097/MOP.0000000000001138
    [10]
    中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 中华肝脏病杂志, 2010, 18(3): 163-166. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY201207005.htm

    Fatty liver and alcoholic liver disease group, Chinese Association of Hepatology. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition[J]. Chinese Journal of Hepatology, 2010, 18(3): 163-166. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY201207005.htm
    [11]
    LI J, ZOU B, YEO Y H, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2019, 4(5): 389-398. doi: 10.1016/S2468-1253(19)30039-1
    [12]
    DONINI L M, PINTO A, GIUSTI A M, et al. Obesity or BMI paradox? Beneath the tip of the iceberg[J]. Front Nutr, 2020, 7: 53. doi: 10.3389/fnut.2020.00053
    [13]
    ZHOU W, SHAN N C, WEI J, et al. Cross-sectional and longitudinal associations between lipid accumulati on product and hyperuricemia[J]. Nutr Metab Cardiovasc Dis, 2022, 32(10): 2348-2355. doi: 10.1016/j.numecd.2022.06.022
    [14]
    LIN I T, LEE M Y, WANG C W, et al. Gender differences in the relationships among metabolic syndrome and various obesity-related indices with nonalcoholic fatty liver disease in a Taiwanese population[J]. Int J Environ Res Public Health, 2021, 18(3): 857. doi: 10.3390/ijerph18030857
    [15]
    ZHANG Y, LI B, LIU N, et al. Evaluation of different anthropometric indicators for screening for no nalcoholic fatty liver disease in elderly individuals[J]. Int J Endocrinol, 2021, 2021: 6678755. DOI: 10.1155/2021/6678755.
    [16]
    PALMA R, PRONIO A, ROMEO M, et al. The role of insulin resistance in fueling NAFLD pathogenesis: from molecular mechanisms to clinical implications[J]. J Clin Med, 2022, 11(13): 3649. doi: 10.3390/jcm11133649
    [17]
    COBOS P, RUIZ M, VILCHES A, et al. Metabolically healthy obesity: inflammatory biomarkers and adipokines in elderly population[J]. PLoS One, 2022, 17(6): e0265362. DOI: 10.1371/journal.pone.0265362.
    [18]
    ANTRACO V, HIRATA B, CRUZ M, et al. Omega-3 polyunsaturated fatty acids prevent nonalcoholic steatohepatit is (NASH) and stimulate adipogenesis[J]. Nutrients, 2021, 13(2): 622. doi: 10.3390/nu13020622
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (213) PDF downloads(21) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return